Duloxetine and Other Antidepressants in the Treatment of Patients with Fibromyalgia
- 1 September 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 8 (suppl 2) , S63-S74
Abstract
To review the use of duloxetine, a new selective serotonin and norepinephrine reuptake inhibitor (SNRI), and other antidepressants in the treatment of patients with fibromyalgia. Two randomized, placebo-controlled, double-blind, parallel-group, 12-week trials of duloxetine in the treatment of fibromyalgia were reviewed. Other published, randomized, placebo-controlled, double-blind trials, and meta-analyses of antidepressant treatment of fibromyalgia were identified by a PubMed search that was augmented by reference cross-check. Duloxetine has been shown to be an effective and safe treatment for many of the symptoms associated with fibromyalgia, particularly for women. Other selective SNRIs also show promise in the treatment of fibromyalgia. Until recently, tricyclic agents that have serotonin and norepinephrine reuptake inhibitory activity had been the most commonly studied group of antidepressants, and they are effective in treating pain and other symptoms associated with fibromyalgia, although their use may be limited by safety and tolerability concerns. There are few randomized, controlled studies of selective serotonin reuptake inhibitors in fibromyalgia, and the results have been mixed. Antidepressants play an important role in the treatment of patients with fibromyalgia. Agents with dual effects on serotonin and norepinephrine appear to have more consistent benefits than selective serotonin antidepressants for the treatment of persistent pain associated with fibromyalgia.Keywords
This publication has 56 references indexed in Scilit:
- Comorbidity of Fibromyalgia and Psychiatric DisordersThe Journal of Clinical Psychiatry, 2006
- Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 studyAnnals of the Rheumatic Diseases, 2004
- Family study of fibromyalgiaArthritis & Rheumatism, 2004
- Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?Expert Opinion on Investigational Drugs, 2002
- Descending control of painProgress in Neurobiology, 2002
- Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal ReceptorsNeuropsychopharmacology, 2001
- Evidence-based data on pain relief with antidepressantsAnnals of Medicine, 2000
- Psychosocial Factors in Fibromyalgia Compared With Rheumatoid ArthritisPsychosomatic Medicine, 1997
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990